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ABSTRACT 
Obesity is considered a chronic low-grade inflammatory status and the stromal vascular 
fraction (SVF) cells of adipose tissue (AT) are considered a source of 
inflammation-related molecules.  We identified YKL-40 as a major protein secreted 
from SVF cells in human visceral AT.  YKL-40 expression levels in SVF cells from 
visceral AT were higher than in those from subcutaneous AT.  Immunofluorescence 
staining revealed that YKL-40 was exclusively expressed in macrophages among SVF 
cells.  YKL-40 purified from SVF cells inhibited the degradation of type I collagen, a 
major extracellular matrix of AT, by matrix metalloproteinase (MMP)-1 and increased 
rate of fibril formation of type I collagen.  The expression of MMP-1 in preadipocytes 
and macrophages was enhanced by interaction between these cells.  These results 
suggest that macrophage/preadipocyte interaction enhances degradation of type I 
collagen in AT, meanwhile, YKL-40 secreted from macrophages infiltrating into AT 
inhibits the type I collagen degradation.   
 
Key words:  YKL-40, MMP-1, type I collagen, adipose tissue, macrophage, 
preadipocyte 
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Introduction 
 
   Adipose tissue (AT) is a critical exchange center for complex energy transactions 
involving triacylglycerol storage and release.  It also has an active endocrine role, 
releasing various adipokines that participate in complex pathways to maintain metabolic 
and vascular health [1].  At present, obesity is considered a low-grade inflammatory 
status, a feature shared with associated pathologies like type 2 diabetes and 
atherosclerosis [2,3].  AT is composed of mature adipocytes and stromal vascular 
fraction (SVF) cells which include preadipocytes, fibroblasts, endothelial cells, 
infiltrating macrophages, etc.  Several experiments suggest that some inflammatory 
factors mostly originate from the non-adipocyte fraction, including infiltrating 
macrophages [4,5].  The amount of infiltrating macrophages that secrete inflammatory 
cytokines such as TNF-α, IL-1α, β, and IL-6 is closely related with AT mass [6,7].  
Preadipocytes in SVF cells have been reported to act as macrophage-like cells and 
secrete inflammatory cytokines [8] and mediate lipopolysaccharide-induced 
inflammation and insulin resistance [9].  Thus, SVF cells including macrophages and 
preadipocytes are thought to be causes of inflammatory status in AT.   
   To identify proteins secreted from human SVF cells, we attempted a proteomic 
analysis of the conditioned medium (CM) of SVF cells fractionated from human AT.  
We found that YKL-40 (also known as HC gp-39 and chitinase 3-like protein 1) is a 
major protein in CM of SVF cells from visceral AT.  YKL-40, a member of the 
mammalian chitinase-like proteins, is expressed and secreted by human synovial cells 
[10,11], chondrocytes [11], smooth muscle cells [12], neutrophils [13], and 
macrophages [14].  Although YKL-40 is classified as a member of glycoside hydrolase 
family 18, which includes bacterial and plant chitinases and retains the capacity to bind 
chitin, it has no chitinase activity [11].  Increased plasma levels of YKL-40 have been 
 4 
found in patients with various pathologies, including arthritis [15], liver fibrosis [15], 
various tumors [15,16], type 2 diabetes [17], and asthma [18].  Recently, YKL-40 
derived from bovine nasal cartilage and chondrocytes was reported to bind type I 
collagen and modulate the rate of type I collagen fibril formation [19].  These reports 
indicate roles for YKL-40 in inflammation and connective tissue remodeling.  
However, the exact function of YKL-40 is yet to be uncovered.  In this study, we 
examined the functions of human YKL-40 secreted from macrophages in AT.  
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Materials and methods 
 
   Subjects.  Fully informed consent was obtained from each patient in accordance 
with institutional guidelines.  The study was approved by our internal review board.  
Seventeen subjects with various tumors participated.  Paired visceral (the omentum) 
and subcutaneous (the abdominal wall) ATs were biopsied from these subjects during 
resection of tumors.  Clinical data are presented in Supplementary Table 1. 
 
   Fractionation of AT.  Visceral or subcutaneous AT was minced and washed with 
PBS containing 2% BSA.  The tissues were digested in minimum essential medium 
(WAKO, Tokyo, Japan) containing 1 mg/ml collagenase S1 (Nitta-Gelatin, Osaka, 
Japan) with shaking at 37˚C for 30 min.  The samples were filtered through a nylon 
mesh and centrifuged at 700 x g for 2 min.  The precipitated SVF cells were washed 
with Ham’s F12 medium (WAKO) containing 10% newborn calf serum (NCS; 
Invitrogen, Carlsbad, CA) three times.  SVF cells were cultured in collagen gels 
(Cellmatrix Collagen Gel Culturing Kit; Nitta-Gelatin) with Ham’s F12 medium 
containing 10% NCS on 6-well plates. 
 
   Mass spectrometry.  SVF cells in collagen gels were incubated with serum–free 
DMEM (WAKO) for 24 h.  The CM was precipitated with cold acetone and the pellet 
after centrifugation was dissolved in PBS containing 0.1% Triton X-100.  The samples 
were subjected to SDS-PAGE, followed by CBB-staining.  Visible bands were excised 
and digested in-gel with Trypsin Gold Mass Spectrometry Grade (Promega, Madison, 
WI).  These samples were desalted using ZipTipC18 pipette tips (Millipore, Bedford, 
MA).  Mass spectrometry of the samples was performed by MALDI-TOF-MS 
(MS/MS 4700 proteomics discovery system; Applied Biosystems, Foster City, CA).  
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The MASCOT peptide mass fingerprint online search engine 
(http://www.matrixscience.com) was used to identify the samples from the NCBI 
non-redundant data-base.  
 
   Cell culture.  SVF cells isolated from human visceral or subcutaneous AT were 
cultured with Ham’s F12 medium supplemented with 10% NCS.  The cells were used 
for experiments after at least three passages in serum-containing medium and were 
defined as passaged preadipocytes, because preadipocytes tended to grow more 
preferentially than other cell types during passage culture of SVF cells.  Human 
monocytic cell lines, THP-1 and U937, were cultured in RPMI 1640 medium (WAKO) 
supplemented with 10% FBS and differentiated into macrophages by 24 h of incubation 
in 100 ng/ml phorbol 12-myristate 13-acetate (Sigma, St Louis, MO).  The 
macrophage-CM was collected after 24 h of incubation with serum-free DMEM. 
 
   RNA extraction and real-time RT-PCR.  Total RNA was isolated from adipocytes, 
preadipocytes, and macrophages differentiated from THP-1 or U937 cells, using 
ISOGEN (Nippongene, Tokyo, Japan).  The total RNA of passaged preadipocytes 
incubated for 24 h with serum-free DMEM with or without 50% macrophage-CM was 
extracted in the same manner.  Each cDNA was prepared by reverse transcription 
using a PrimeScriptTM RT Reagent Kit (TaKaRa, Shiga, Japan).  The mRNA levels of 
various proteins were analyzed by SYBR green quantitative real-time RT-PCR with a 
specific primer set (see Supplementary Table 2) using a 7300 real-time PCR system 
(Applied Biosystems).  The mRNA level of each target gene was normalized using 
GAPDH as an internal control.  
 
   Immunofluorescence staining.  The cells were cultured on 6-well plates and rinsed 
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in PBS and then fixed in 10% formaldehyde.  Fixed cells were incubated first with 
0.1% Triton X-100 for 10 min followed by blocking solution (Blocking One: Nacalai 
Tesque, Kyoto, Japan) for 1 h.  The cells were incubated with a 1:500 dilution of 
mouse anti-human YKL-40 antibody (QUIDEL, San Diego, CA) and 1:500 dilution of 
rabbit anti-MMP-1 antibody (Chemicon, Temecula, CA) or 1:500 dilution of rabbit 
anti-CD68 antibody (Santa Cruz, Santa Cruz, CA) for 2 h, and then incubated with a 
1:1,000 dilution of Alexa Fluor 488 goat anti-mouse IgG or Alexa Fluor 568 goat 
anti-rabbit IgG (Invitrogen) for 30 min at 37˚C.  The cells were observed under a 
fluorescence microscope. 
   
   Purification of YKL-40.  SVF cells were incubated with serum–free DMEM for 24 
h in collagen gels.  The CM of 300 ml was fractionated by a 10-ml Gelatin-Sepharose 
4B (GE Healthcare, Uppsala, Sweden) column.  The non-gelatin-bound fraction was 
then passed through a 5-ml Hitrap Heparin HP column (GE Healthcare) equilibrated 
with 0.1 M phosphate buffer (pH 7.4).  The heparin-bound material was eluted 
sequentially with 0.1 M phosphate buffer (pH 7.4) containing 300 mM, 400 mM, 500 
mM, and 1 M NaCl with an AKTAprime chromatography system (GE Healthcare).  
Fractions eluted by 400 mM NaCl were concentrated with Centriplus YM-3K 
(Millipore).  
 
   Measurement of collagenolytic activity.  The assay was performed as directed by 
the protocol of the Type I Collagenase Activity Assay Kit (LIFE, Yamagata, Japan) 
with some modifications.  Briefly, mixtures with final concentrations of 250 µg/ml of 
FITC-labeled type I collagen from calf skin, various concentrations of purified YKL-40, 
human MMP-1 active form, and ice cold 1 x neutralization buffer supplied with the kit 
in 200 µl were incubated at 37˚C for 1 h.  Samples were denatured with 200 µl of 
 8 
denature/stop solution supplied with the kit for 30 min at room temperature and then 
centrifuged at 6,000 x g for 15 min.  The fluorescence of the supernatant was measured 
with a fluorescence spectrophotometer.  
 
   Collagen fibril formation assay.  One mg of type I collagen (Nitta-Gelatin) was 
added to 0.5 ml of fibrillogenesis buffer (0.15 M NaCl, 60 mM NaHCO3, 40 mM 
HEPES, pH 7.4).  Purified YKL-40 or heat-denatured BSA was added to the sample, 
and the final volume was brought to 1.0 ml.  This mixture was transferred to a cuvette 
and incubated at 37˚C.  The process of fibrillogenesis was measured as turbidity 
change by monitoring the change in absorbance at 400 nm.   
 
   Measurement of matrix metalloproteinases (MMPs) in CM.  Passaged 
preadipocytes were cultured for 24 h in serum-free DMEM with or without 50% 
macrophage-CM.  After washing with PBS three times, the cells were cultured in fresh 
serum-free DMEM for 24 h and each CM was collected.  Concentrations of MMP-1 
and -2 in the CM were measured with MMP-1 and -2 Human Biotrak ELISA systems 
(GE Healthcare), respectively. 
 
   Statistical analysis.  Correlation between YKL-40 and CD68 mRNA levels was 
assessed by Pearson correlations with SPSS14.0 for Windows (SPSS Inc., Chicago, IL).  
Statistical analysis was performed using a Student t-test to compare differences in 
values between the control and samples.  A p value of less than 0.05 represented a 
statistically significant difference between compared data sets.   
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Results 
 
Identification of YKL-40 as a major protein secreted from SVF cells 
 
   To investigate the proteins secreted from SVF cells, SDS-PAGE and proteomic 
analysis of each CM collected from SVF cells fractionated from human visceral and 
subcutaneous ATs were performed.  In the CM of SVF cells from subcutaneous AT 
(sSVF), no specific bands except for that of albumin derived from calf serum were 
observed, whereas several bands were detected in the CM of SVF cells from visceral 
AT (vSVF) (Fig. 1A).  To identify these proteins secreted from vSVF cells, visible 
bands were excised from gels and subjected to MALDI-TOF MS.  Among the 
candidates, YKL-40 (40 kDa) was identified as the most abundant protein in CM of 
vSVF cells (Fig 1A).  Real-time RT-PCR revealed that YKL-40 mRNA levels were 
higher in vSVF cells than in sSVF cells similar to the protein levels (Fig. 1B). 
 
YKL-40 is secreted from macrophages among SVF cells 
 
   Because the primary SVF cells used for proteomic analysis included preadipocytes, 
macrophages, vascular endothelial cells, etc, identification of cells secreting YKL-40 
among SVF cells was attempted.  Immunostaining of vSVF cells revealed that the 
YKL-40-positive cells coincided with the cells expressing CD68, a macrophage marker 
(Fig. 1C).  Furthermore, YKL-40 mRNA levels in each passaged preadipocyte derived 
from vSVF and sSVF cells were measured.  YKL-40 mRNA levels in the 
preadipocytes from both visceral and subcutaneous AT were remarkably low compared 
with those in macrophages (Fig. 1D).  These results suggest that YKL-40 was secreted 
from macrophages among SVF cells, but not preadipocytes.  Furthermore, YKL-40 
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mRNA levels were positively correlated with CD68 mRNA levels in both visceral and 
subcutaneous ATs (Fig. 1E), suggesting that YKL-40 expression levels may reflect 
numbers of macrophages infiltrating into AT.  To deny a possibility that YKL-40 
expression in AT is specific in subjects with tumors, immunofluorescence staining of 
sections of visceral AT from a subject without tumors and inflammatory lesions was 
performed (see Supplemental Figure).  The YKL-40-positive signals were observed in 
CD68-positive cells, indicating that YKL-40 expression in macrophages infiltrating into 
AT was independent of tumor or inflammatory lesions.  
 
YKL-40 derived from SVF cells inhibits the collagenolytic activity of MMP-1 
 
   Type I collagen dominates the ECM of normal white ATs [20].  To investigate 
whether YKL-40 in SVF cells affects degradation of type I collagen, we attempted to 
purify YKL-40 secreted from vSVF cells.  After SDS-PAGE and silver-staining, the 
single band was confirmed as YKL-40 by mass spectrometry (Fig. 2A).  The purified 
YKL-40 inhibited dose-dependently the degradation of type I collagen by MMP-1 even 
in the presence of high concentration of MMP-1 (Fig. 2B).  Furthermore, fibril 
formation assay revealed that YKL-40 increased the rate and the final quantity of 
collagen fibril formation (Fig. 2C).  
 
Macrophage-CM increases MMP expressions in preadipocytes  
 
   To investigate under what circumstances MMP-1 expression is enhanced in AT, we 
measured MMP-1 mRNA levels in passaged preadipocytes stimulated by CM of 
macrophages differentiated from THP-1 or U937 cells.  The addition of 
macrophage-CM significantly induced mRNA expression of MMP-1, but not MMP-2 in 
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preadipocytes derived from visceral AT (Fig. 3A).  Furthermore, monocyte 
chemoattractant protein-1 (MCP-1) mRNA levels were also increased by 
macrophage-CM (Fig. 3A).  The macrophage-CM induced MMP-1’s secretion from 
preadipocytes, but not MMP-2’s secretion in a similar pattern to the mRNA levels (Fig. 
3B).  These results suggest that soluble factors secreted by macrophages induced 
MMP-1’s expression in preadipocytes.  
 
Co-culture of preadipocytes and macrophages increases MMP-1 expression 
 
   Next, to investigate the expression of MMP-1 in AT accompanied by the infiltration 
of macrophages, we performed immunocytochemistry of co-cultured preadipocytes and 
macrophages.  Immunostaining using anti-YKL-40 and anti-CD68 antibodies revealed 
that YKL-40 was exclusively expressed in CD-68-positive cells (Fig. 4A). Although 
little MMP-1 protein was observed in macrophages or preadipocytes in single cultures, 
the co-culture of preadipocytes and macrophages markedly increased MMP-1 protein 
expression in both YKL-40-positive and negative cells (Fig. 4B).  These results 
suggested that interaction between preadipocytes and macrophages induced production 
and secretion of MMP-1 in both cells. 
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Discussion 
 
   We identified YKL-40 as a major protein secreted from vSVF cells.  SDS-PAGE 
and real-time RT-PCR revealed that the secretion and the gene expression of YKL-40 
were greater in vSVF than in sSVF.  This might be caused by a difference in the 
numbers of macrophages among SVF cells from each AT, because the infiltration of 
macrophages into visceral AT is greater than that into subcutaneous AT [21].  Indeed, 
we showed that YKL-40 was expressed in macrophages among SVF cells and the 
mRNA levels in both visceral and subcutaneous ATs correlated with the CD68 mRNA 
levels, suggesting that YKL-40 expression levels in AT were dependent on the number 
of macrophages in AT.  We could not rule out the possibility that the expression of 
YKL-40 was dependent on tumor status, because plasma levels of YKL-40 are known 
to be increased in various cancer patients [15,16].  However, immunohistochemical 
study of AT from a subject without tumors and inflammatory lesions at least revealed 
that macrophages in AT secrete YKL-40 in subjects without tumors. 
   Bigg et al. [19] reported that YKL-40 in bovine nasal cartilage and chondrocytes 
has three isoforms, a major and minor form from resorbing cartilage and a third species 
from chondrocytes.  The chondrocyte-derived species prevents cleavage of type I 
collagen and stimulates the rate of fibril formation of type I collagen.  On the other 
hand, the major form from cartilage had an inhibitory effect on the formation of type I 
collagen fibrils.  These indicate that YKL-40 derived from different tissues may have 
different roles.  We found that YKL-40 derived from human vSVF cells has the 
function of YKL-40 in human SVF cells is similar to that of the chondrocyte-derived 
species rather than the major form from cartilage in bovine. 
   The mRNA expressions of MMP-1 and MCP-1 in preadipocytes were enhanced by 
addition of macrophage-CM, suggesting that MMP-1 and MCP-1 expression in 
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preadipocytes is induced under condition that macrophage is activated by some 
inflammatory signals.  MMPs are thought to be involved in the infiltrations of 
inflammatory cells such as macrophages by degradation of the ECM, and MCP-1 is 
known to affect the accumulation and function of macrophages and the expression has 
been found in SVF cells and increases in obese subjects [22].  Induction of MMP-1 
and MCP-1 in preadipocytes may coordinately contribute to the infiltration of 
macrophages into AT by cleaving type I collagen of AT to facilitate the infiltration and 
by chemo-attracting macrophages into AT, respectively.  
   In vitro study revealed that YKL-40 blocked degradation of type I collagen 
dose-dependently, irrespective of the concentration of MMP-1.  YKL-40 purified from 
vSVF cells inhibited the degradation of type I collagen by MMP-1 at a final 
concentration 100 ng/ml and more.  The effective concentration of YKL-40 was 
regarded as physiological because most reports showed that the range of YKL-40 
plasma levels is 25 - 200 ng/ml [15,17,18] and the local concentration of YKL-40 in AT 
is presumably higher than this.   Although stoichiometric relation between YKL-40 
levels and MMP-1 activity in the vicinity of AT-infiltrating macrophages in vivo 
remains unclear, degradation of type I collagen may be strongly inhibited at the location 
with high concentration of YKL-40 such as neighborhood of macrophages, even if 
interaction between macrophages and preadipocytes increases MMP-1 expression.  
Therefore, YKL-40 secreted from macrophages in AT may contribute to trap 
macrophages into AT by inhibition of type I collagenolysis by MMP-1. 
   Taken together, our results suggest the preliminary hypothesis about 
macrophage-infiltration into AT; macrophages activated by inflammatory signals 
induce MMP-1 and MCP-1 expression in preadipocytes to infiltrate macrophages into 
AT, and then YKL-40 in infiltrating macrophages reduces MMP-1 activity and 
accelerates the fibril formation at vicinity of macrophages to trap macrophages in AT.  
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To demonstrate this hypothesis, further investigations are necessary. 
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Figure legends 
 
Fig. 1 YKL-40 secreted from macrophages among human SVF cells.  (A) 
SDS-PAGE and CBB-staining of CM of SVF cells.  YKL-40 was identified as the 
most remarkable band in CM of vSVF cells.  (B) YKL-40 mRNA levels in paired 
vSVF and sSVF cells from 17 patients.  The data are plotted with lines connecting the 
mRNA levels of vSVF and sSVF cells from the same participants.  Mean values for 
overall group of each SVF cell are also indicated (horizontal bars).  P < 0.05.  (C) 
Detection of cells expressing YKL-40 among vSVF cells by immunostaining with 
anti-YKL-40 (green) and anti-CD68 (red) antibodies.  (D) YKL-40 mRNA levels in 
macrophages differentiated from THP-1 cells and respective passaged preadipocytes 
fractionated from visceral (vPreadipocyte) and subcutaneous (sPreadipocyte) AT.  The 
data are the mean ± SEM for three independent experiments in triplicate (n=9).  (E) 
Correlation between YKL-40 and CD68 mRNA levels in visceral or subcutaneous AT 
in 17 subjects. 
 
Fig. 2 The effect of YKL-40 purified from vSVF on collagen degradation.  (A) 
Silver staining of YKL-40 purified from CM of vSVF cells.  (B) Dose-effect of 
MMP-1 on collagenolytic activity in the presence of various YKL-40 concentrations.  
The collagenolytic activity was presented as the percentage of fluorescent intensity 
derived from collagen degraded per hour.  The data are the mean ± SEM for three 
independent experiments in triplicate (n=9).  P < 0.05.  (C) Effect of YKL-40 on 
type I collagen fibril formation.  Purified YKL-40 or heat-denatured BSA was added 
to type I collagen dissolved in fibril formation buffer and incubate at 37˚C during 
indicating time.  The data are the mean ± SEM for three independent experiments in 
triplicate (n=9). P < 0.05. 
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Fig. 3 MMPs expression in passaged preadipocytes derived from vSVF treated with 
macrophage-CM or inflammatory cytokines.  (A) Effect of macrophage-CM on 
mRNA levels of MMP-1 and -2 in preadipocytes.  Each mRNA level was measured in 
preadipocytes which were cultured for 24 h in serum-free DMEM (open column) or 
50% CM of macrophages differentiated from THP-1 (gray column) and U937 (black 
column).  (B) Effect of macrophage-CM on secretion of MMP-1 and -2 from 
preadipocytes.  Incubation with serum-free DMEM and 50% CM of macrophages 
derived from THP-1 cells for 24 h is represented by an open column and a filled column, 
respectively.  Each graph shown is representative of three independent experiments.  
Values are expressed as the mean ± SEM (n=3).  P < 0.05.  
 
Fig. 4 MMP-1 expression in co-culture of preadipocytes derived from vSVF and 
macrophages.  (A) Detection of YKL-40-expressing cells (green) in co-cultures of 
preadipocytes and macrophages using anti-CD68 antibody (red).  YKL-40 expressed 
in only CD68 positive cells.  (B) Immunocytochemistry using anti-YKL-40 (green) 
and anti-MMP-1 (red) antibodies in co-cultures of preadipocytes and macrophages, or 
in single-cultures of each cell type.  
 




Supplemental data 
 
YKL-40 secreted from adipose tissue inhibits degradation of type I collagen 
Iwata et al.  
 
Supplementary Table 1  Clinical data of obesity and cancer types of subjects who 
participated in this study. 
 
 
Visceral and subcutaneous adipose tissue areas at the umbilical level in abdominal 
computed tomography were determined using commercially available software (Fat 
Scan; N2 System, Osaka, Japan).  The subjects did not receive chemotherapy or 
radiotherapy before surgical operation.   
Suplementary Table 2  Sequences of the PCR primers used for real-time RT-PCR in 
this study 
 
          
PCR products    Primer Sequence 
Human GAPDH F 5'-GAAGGTGAAGGTCGGAGTC-3' 
R 5'-GAAGATGGTGATGGGATTTC-3' 
Human YKL-40 F 5'-AAGGACACCATTTTGGCAAG-3' 
R 5'-AGTGGGCGCTCAAAGATAGA-3' 
Human CD68 F 5'-GCTGGCTGTGCTTTTCTCG-3' 
R 5'-GTCACCGTGAAGGATGGCA-3' 
Human MMP-1 F 5'-ATGCTGAAACCCTGAAGGTG-3' 
R 5'-CTGCTTGACCCTCAGAGACC-3' 
Human MMP-2 F 5'-ATGACAGCTGCACCACTGAG-3' 
R 5'-ATTTGTTGCCCAGGAAAGTG-3' 
Human MCP-1 F 5'-CCCCAGTCACCTGCTGTTAT-3' 
R 5'-TGGAATCCTGAACCCACTTC-3' 
 
 
Supplementary Figure 
 
Supplementary Figure.  Detection of YKL-40 positive cells in visceral AT from a 
subject without tumors or inflammatory lesions.  Paraffin sections of omental AT 
removed from a subject without tumors or inflammatory lesions were incubation 
overnight at 4˚C with 1:100 dilution of mouse anti-human YKL-40 antibody and 1:100 
dilution of rabbit anti-CD68 antibody.  After three washes in PBS, the sections were 
stained with Alexa Fluor 488 donkey anti-mouse IgG and Alexa Fluor 568 goat 
anti-rabbit IgG as the second antibodies for 30 min.  The sections were visualized with 
a laser scanning confocal microscope (Carl Zeiss, Jena, Germany).  Negative controls 
were used by omitting the primary antibody.  Some sections were stained with 
hemotoxylin and eosin (H&E), and examined by light microscopy.  (A) H&E staining 
of sections from visceral AT.  (B) Immunostaining of sections of visceral AT with 
anti-YKL-40 (green) and anti-CD68 (red) antibodies.    
